Approval · Notice of Compliance 5970 · 1998
CAVERJECT: Notice of Compliance 5970
Issued April 30, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5970
- Date
- April 30, 1998
- Company
- Pharmacia & Upjohn Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosage form
- Therapeutic class
- Prostaglandin
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CAVERJECT | 02237799 | — |
| CAVERJECT | 02237800 | — |
| CAVERJECT | 02237801 | — |
Medicinal ingredients
- ALPROSTADIL 5 MCG per ML
- ALPROSTADIL 10 MCG per ML
- ALPROSTADIL 20 MCG per ML